4746 — Formosa Laboratories Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual cashflow statement for Formosa Laboratories, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-40.2	361	1,088	333	142
Depreciation
Amortisation
Non-Cash Items	55.5	-305	-1,246	-126	450
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-110	-31.1	-5.34	-35.5	-254
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	290	475	311	643	827
Capital Expenditures	-1,421	-1,011	-514	-440	-541
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-58.7	150	-75.7	-101	-717
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-1,480	-861	-589	-541	-1,257
Financing Cash Flow Items	0	161	532	272	584
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	773	516	439	448	700
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-418	127	149	550	247